Karim Vermaelen
Overview
Explore the profile of Karim Vermaelen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
2173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Lorenzi L, Chiu H, Avila Cobos F, Gross S, Volders P, Cannoodt R, et al.
Nat Biotechnol
. 2021 Jun;
39(11):1467.
PMID: 34183863
No abstract available.
12.
Lorenzi L, Chiu H, Avila Cobos F, Gross S, Volders P, Cannoodt R, et al.
Nat Biotechnol
. 2021 Jun;
39(11):1453-1465.
PMID: 34140680
Existing compendia of non-coding RNA (ncRNA) are incomplete, in part because they are derived almost exclusively from small and polyadenylated RNAs. Here we present a more comprehensive atlas of the...
13.
Stevens D, Ingels J, Van Lint S, Vandekerckhove B, Vermaelen K
Front Immunol
. 2021 Mar;
11:620374.
PMID: 33679709
Lung cancer remains the leading cause of cancer-related death worldwide. The advent of immune checkpoint inhibitors has led to a paradigm shift in the treatment of metastatic non-small cell and...
14.
Van Hoecke L, Verbeke R, Dewitte H, Lentacker I, Vermaelen K, Breckpot K, et al.
Mol Cancer
. 2021 Mar;
20(1):48.
PMID: 33658037
mRNA therapeutics have become the focus of molecular medicine research. Various mRNA applications have reached major milestones at high speed in the immuno-oncology field. This can be attributed to the...
15.
De Keukeleire S, Vermassen T, Nezhad Z, Kerre T, Kruse V, Van Vlierberghe H, et al.
Immunotherapy
. 2021 Jan;
13(5):409-418.
PMID: 33487052
More patients with chronic hepatitis B and C infection are being exposed to immune checkpoint inhibitors (ICIs), but the safety and efficacy of ICIs in patients with chronic viral hepatitis...
16.
Castro F, Pinto M, Pereira C, Serre K, Barbosa M, Vermaelen K, et al.
Biomaterials
. 2020 Aug;
257:120218.
PMID: 32736253
Radiotherapy (RT) is an essential treatment modality for several types of cancer. Despite its therapeutic potential, RT is frequently insufficient to overcome the immunosuppressive nature of the tumor microenvironment, failing...
17.
Raman L, Van der Linden M, Van der Eecken K, Vermaelen K, Demedts I, Surmont V, et al.
Genome Med
. 2020 Apr;
12(1):35.
PMID: 32317009
Background: Accurate lung cancer classification is crucial to guide therapeutic decisions. However, histological subtyping by pathologists requires tumor tissue-a necessity that is often intrinsically associated with procedural difficulties. The analysis...
18.
Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T, Prencipe G, et al.
Ann Rheum Dis
. 2020 Apr;
79(7):960-968.
PMID: 32312770
Background And Objective: Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease (AID) worldwide. The disease is caused by mutations in the gene encoding the inflammasome sensor Pyrin....
19.
Ingels J, De Smet S, Heyns K, Lootens N, Segaert J, Taghon T, et al.
Acta Clin Belg
. 2020 Apr;
76(6):482-486.
PMID: 32285755
Cytomegalovirus (CMV) infection is one of the most common complications in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. The classic antiviral treatments have shown clinical efficacy but are often associated...
20.
De Keukeleire S, Vermassen T, De Schoenmakere G, Kruse V, Vermaelen K, Rottey S
Acta Clin Belg
. 2019 Jul;
75(6):434-441.
PMID: 31357914
: Assessing the safety and efficacy of immune checkpoint inhibition in risky cancer patient subgroups: pre-existing organ failure, elderly, presence of auto-immune disease, transplanted patients and brain metastasis treated with...